Aortech International PLC
24 January 2006
For Immediate Release 24 January 2006
AorTech International plc
('AorTech' or 'the Company')
AorTech Awarded Australian Government Grant Funding
AorTech International has been awarded grant funding from various Australian
Government Agencies to support its investment in R&D activities and
infrastructure. The anticipated total grant for the first half of 2006 is
approximately $1 million AUD (approx. £422,000). It is AorTech's intention to
move the headquarters of its Australian Operations to an expanded facility in
Melbourne.
This funding support has been obtained from these government grant schemes which
have been established to support the investment in R&D, infrastructure and
growth of high-tech businesses in Australia. The company expects the bulk of the
remaining funds will be received later this quarter with the balance expected in
Q2, subject to AorTech's completion of milestones for funding.
The biotech industry is a vibrant and growing sector of the Australian economy,
underpinned by world-leading research and clinical facilities, and strong
government commitment. This environment is well aligned with the next phases of
expansion of AorTech's business.
For further information please contact:
AorTech International plc
Frank Maguire, Chief Executive 00 1 801 201 4336
Buchanan Communications 020 7466 5000
Ben Willey, Rebecca Skye Dietrich
Visit AorTech's website at: www.aortech.com
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.